Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 9—September 2020
Dispatch

Emergence of pstS-Null Vancomycin-Resistant Enterococcus faecium Clone ST1478, Canada, 2013–2018

Melissa McCrackenComments to Author , Robyn Mitchell, Stephanie Smith, Susy Hota, John Conly, Tim Du, John Embil, Lynn Johnston, Debbie Ormiston, Jennifer Parsonage, Andrew Simor, Alice Wong, George Golding, and for the Canadian Nosocomial Infection Surveillance Program
Author affiliations: Public Health Agency of Canada, Winnipeg, Manitoba, Canada (M. McCracken, T. Du, G. Golding); Public Health Agency of Canada, Ottawa, Ontario, Canada (R. Mitchell); University of Alberta, Edmonton, Alberta, Canada (S. Smith); Toronto General Hospital, Toronto, Ontario, Canada (S. Hota); University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada (J. Conly); Health Sciences Centre, Winnipeg (J. Embil, D. Ormiston); Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada (L. Johnston); University of Alberta Hospital, Edmonton (J. Parsonage); Sunnybrook Health Sciences Centre, Toronto (A. Simor); Saskatchewan Health Authority, Saskatoon, Saskatchewan, Canada (A. Wong)

Main Article

Table 2

Characteristics for patients with ST1478 versus non-ST1478 vancoymicin-resistant enterococci bloodstream infections, Canada, 2013–2018*

Characteristic ST1478, n = 110 Non-ST1478, n = 492 p value
Mean age, y (SD)
58 (16.8)
59 (17.5)
0.89
Sex
M 69/110 (62.7) 296/492 (60.2) 0.62
F
41/110 (73.3)
196/492 (39.8)
0.62
Central venous catheter 57/82 (69.5) 184/251 (73.3) 0.50
Solid organ transplant 24/97 (24.7) 42/325 (12.9) 0.005
Hemodialysis 15/70 (21.4) 47/223 (21.1) 0.95
Chemotherapy
11/70 (15.7)
54/223 (24.2)
0.14
ICU admission within 30 d of positive blood culture 11/91 (12.1) 60/332 (18.1) 0.18
30 d all-cause mortality rate 35/108 (32.4) 120/390 (30.8) 0.75

*Values are no. positive/no. tested (%) unless indicated otherwise. ICU, intensive care unit.

Main Article

Page created: May 29, 2020
Page updated: August 19, 2020
Page reviewed: August 19, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external